Results
|
171341.
|
|
|
171342.
|
|
|
171343.
|
|
|
171344.
|
|
|
171345.
|
|
|
171346.
|
|
|
171347.
|
|
|
171348.
|
|
|
171349.
|
|
|
171350.
|
|
|
171351.
|
|
|
171352.
|
Comparisons between in-vitro and in-vivo metabolism of (S)-warfarin: catalytic activities of cDNA-expressed CYP2C9, its Leu359 variant and their mixture versus unbound clearance in patients with the corresponding CYP2C9 genotypes. [electronic resource] by
- Takahashi, H
- Kashima, T
- Nomoto, S
- Iwade, K
- Tainaka, H
- Shimizu, T
- Nomizo, Y
- Muramoto, N
- Kimura, S
- Echizen, H
Producer: 19990114
In:
Pharmacogenetics vol. 8
Availability: No items available.
|
|
171353.
|
|
|
171354.
|
|
|
171355.
|
|
|
171356.
|
The CXC chemokine murine monokine induced by IFN-gamma (CXC chemokine ligand 9) is made by APCs, targets lymphocytes including activated B cells, and supports antibody responses to a bacterial pathogen in vivo. [electronic resource] by
- Park, Matthew K
- Amichay, Doron
- Love, Paul
- Wick, Elizabeth
- Liao, Fang
- Grinberg, Alex
- Rabin, Ronald L
- Zhang, Hongwei H
- Gebeyehu, Senkuta
- Wright, Timothy M
- Iwasaki, Akiko
- Weng, Youmin
- DeMartino, Julie A
- Elkins, Karen L
- Farber, Joshua M
Producer: 20020813
In:
Journal of immunology (Baltimore, Md. : 1950) vol. 169
Availability: No items available.
|
|
171357.
|
|
|
171358.
|
|
|
171359.
|
|
|
171360.
|
|